Covered recipient · General Payments record
JOSEPH A RACANELLI
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$34,803.12
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $12,750.00 | 6 |
| Food and Beverage | $125.88 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Royal Biologics | $12,750.00 | 6 |
| GlaxoSmithKline, LLC. | $107.69 | 4 |
| Acera Surgical, Inc. | $18.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acera Surgical, Inc. | $18.19 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152415956 | CMS |
| GlaxoSmithKline, LLC. | $31.15 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116424767 | CMS |
| GlaxoSmithKline, LLC. | $25.61 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116652819 | CMS |
| GlaxoSmithKline, LLC. | $28.35 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116578574 | CMS |
| GlaxoSmithKline, LLC. | $22.58 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116382004 | CMS |
| Royal Biologics, Inc. | $850.00 | 05/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089267 | CMS |
| Royal Biologics, Inc. | $3,400.00 | 05/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089269 | CMS |
| Royal Biologics, Inc. | $5,100.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089271 | CMS |
| Royal Biologics, Inc. | $850.00 | 08/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089273 | CMS |
| Royal Biologics, Inc. | $850.00 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089275 | CMS |
| Royal Biologics, Inc. | $1,700.00 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089277 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.